Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | 7819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| SID 26681509 | C27H33N5O5S | 958772-66-2 | Details |
| Cisapride | C23H29ClFN3O4 | 81098-60-4 | Details |
| SMN-C3 | C24H28N6O | 1449597-34-5 | Details |
| Sigma-1 receptor antagonist 3 | C19H23ClFN3O | 1639220-17-9 | Details |
| Silvestrol aglycone (enantiomer) | C27H26O8 | 1112993-18-6 | Details |
| Silvestrol aglycone | C27H26O8 | 960365-65-5 | Details |
| SJB3-019A | C16H8N2O3 | 2070015-29-9 | Details |
| Sirtuin modulator 1 | C31H32ClN5O2S2 | 2070015-26-6 | Details |
| Sitaxsentan | C18H15ClN2O6S2 | 184036-34-8 | Details |
| SIS3 free base | C28H27N3O3 | 1009104-85-1 | Details |
| Sitravatinib malate；MGCD516 malate;MG-516 malate | C37H35F2N5O9S | 2244864-88-6 | Details |
| SK1-IN-1 | C22H30N4O3 | 1218816-71-7 | Details |
| SKF-34288 hydrochloride | C6H6ClNO2S | 320386-54-7 | Details |
| Sofosbuvir impurity C | C22H29FN3O9P | 1496552-28-3 | Details |
| 4-Aminosalicylic acid；Aminopar;Aminosalicylic acid;para-aminosalicylic acid;4-aminosalicylate | C7H7NO3 | 65-49-6 | Details |
| Sofosbuvir impurity F；Sofosbuvir 3',5'-Bis-(S)-phosphate | C34H45FN4O13P2 | 1337482-17-3 | Details |
| PSI-7976 | C22H29FN3O9P | 1190308-01-0 | Details |
| Sofosbuvir impurity G | C22H29FN3O9P | 1337482-15-1 | Details |
| Sodium Channel inhibitor 1 | C24H19F4N3O3 | 1198117-23-5 | Details |
| Sofosbuvir impurity J | C22H30FN4O8P | 1334513-10-8 | Details |
| Sigma-1 receptor antagonist 1 | C19H23Cl2N3O | 1639220-19-1 | Details |
| SIRT-IN-2 | C15H21N5O3S2 | 1431411-66-3 | Details |
| Sigma-1 receptor antagonist 2 | C20H26ClN3O2 | 1639220-15-7 | Details |
| Sofosbuvir impurity K | C22H29ClN3O9P | 1496552-51-2 | Details |
| Sofosbuvir impurity M | C22H30N3O10P | 2095551-10-1 | Details |
| Sodium copper chlorophyllin B | C34H29CuN4NaO7(-2) | 28302-36-5 | Details |
| Sodium citrate dihydrate | C6H9Na3O9 | 6132-04-3 | Details |
| Sodium laureth sulfate | (C2H4O)nC12H26O4S.Na | 9004-82-4 | Details |
| Fleroxacin | C17H18F3N3O3 | 79660-72-3 | Details |
| SN 2 | C17H21NO | 823218-99-1 | Details |
| SNDX-5613 | C32H47FN6O4S | 2169919-21-3 | Details |
| SMAP-2；DT-1154 | C27H27F3N2O4S | 1809068-70-9 | Details |
| SMS1-IN-1 | C23H23BrN2O4S | 1807943-38-9 | Details |
| SMP-028 | C23H26FN5O2S | 914389-14-3 | Details |
| SMS2-IN-1 | C34H37F6N3O5 | 2098890-15-2 | Details |
| SMYD2-IN-1 | C25H25Cl2F2N7O2 | 2023788-96-5 | Details |
| SMYD3-IN-1 | C28H31ClN4O3 | 2095160-79-3 | Details |
| SN50 | C129H230N36O29S | 213546-53-3 | Details |
| SNT-207707 | C32H44ClN5O | 1064662-40-3 | Details |
| SNT-207858 free base | C32H43Cl2N5O3 | 1104662-66-9 | Details |
| SOCE inhibitor 1 | C25H22F3N5O4 | 2169316-15-6 | Details |
| SNT-207858 | C32H45Cl4N5O3 | 1104080-42-3 | Details |
| Gatifloxacin | C19H22FN3O4 | 112811-59-3 | Details |
| SLC13A5-IN-1 | C19H19Cl3N2O3S | 2227548-95-8 | Details |
| Eugenol | C10H12O2 | 97-53-0 | Details |
| Solanidine | C27H43NO | 80-78-4 | Details |
| Solenopsin | C17H35N | 137038-57-4 | Details |
| Solifenacin D5 hydrochloride | C23H22D5ClN2O2 | 1426174-05-1 | Details |
| Soluble epoxide hydrolase inhibitor | C18H12F5N5O3 | 1241826-88-9 | Details |
| Sootepin D | C31H48O4 | 1154518-97-4 | Details |
| Clofibrate；Clofibrato;Ethyl clofibrate;Clofibratum | C12H15ClO3 | 637-07-0 | Details |
| STAT3-IN-1 | C28H29NO6 | 2059952-75-7 | Details |
| SSTR5 antagonist 1 | C28H34FN3O5 | 1628741-91-2 | Details |
| Sparfosic acid trisodium | C6H11NNaO8P | 70962-66-2 | Details |
| Spastazoline | C20H30N8 | 2351882-11-4 | Details |
| SPD304 dihydrochloride | C32H33ClF3N3O2 | 1049741-03-8 | Details |
| 3-Pyridinemethanol | C6H7NO | 100-55-0 | Details |
| SSR128129E free acid；SSR free acid | C18H16N2O4 | 848463-13-8 | Details |
| SSR-241586 | C32H42Cl2N4O3 | 1239279-30-1 | Details |
| SRT3657 | C40H54N8O6S | 1383551-17-4 | Details |
| Squalamine lactate；MSI-1256F | C37H71N3O8S | 320725-47-1 | Details |
| Squalamine；MSI-1256 | C34H65N3O5S | 148717-90-2 | Details |
| ST1936 oxalate | C15H19ClN2O4 | 1782228-83-4 | Details |
| ST-193 | C24H25N3O | 489416-12-8 | Details |
| Guaiacol | C7H8O2 | 90-05-1 | Details |
| sPLA2-X Inhibitor 31 | C19H15F3N2O4 | 2241025-50-1 | Details |
| SPL-410 | C24H31F3N2O4S | 2351886-00-3 | Details |
| Spiramycin I | C43H74N2O14 | 24916-50-5 | Details |
| Spirodiclofen | C21H24Cl2O4 | 148477-71-8 | Details |
| Siomycin A | C71H81N19O18S5 | 12656-09-6 | Details |
| SIRT5 inhibitor 1 | C31H39FN6O6S2 | 2166487-21-2 | Details |
| Sirt2-IN-1 | C28H27N7O2S2 | 1862238-00-3 | Details |
| Tiapride hydrochloride | C15H25ClN2O4S | 51012-33-0 | Details |
| 5-HT3 antagonist 2 | C18H21N3O | 128199-93-9 | Details |
| SQ-31765；SQ31765;SQ 31765 | C24H27F3N2O4 | 138383-07-0 | Details |
| SR10067 | C31H31NO3 | 1380548-02-6 | Details |
| SQ28603；Squibb 28603;SQ28,603 | C13H17NO3S | 100845-83-8 | Details |
| SR121566A | C20H25N5O4S | 180144-61-0 | Details |
| SP-8356 | C18H20O4 | 1454885-45-0 | Details |
| NSC-70220；SOS1-IN-1 | C22H15NO2 | 4551-00-2 | Details |
| Soraprazan；BYK61359 | C21H25N3O3 | 261944-46-1 | Details |
| Sorafenib-d4；Bay 43-9006 (D4);Sorafenib (D4) | C21H16ClF3N4O3 | 1207560-07-3 | Details |
| BI-3406 | C23H25F3N4O3 | 2230836-55-0 | Details |
| Solabegron | C23H23ClN2O3 | 252920-94-8 | Details |
| Sodium formononetin-3'-sulfonate；Sul-F | C15H9NaO7S | 949021-68-5 | Details |
| Sodium Channel inhibitor 2 | C26H25Cl2N3O | 653573-60-5 | Details |
| Sofosbuvir impurity N | C20H25FN3O9P | 1394157-34-6 | Details |
| SK33 | C20H13F9N2O3 | 1928724-23-5 | Details |
| Siltenzepine | C19H20ClN3O4 | 98374-54-0 | Details |
| Siguazodan；SKF 94836 | C14H16N6O | 115344-47-3 | Details |
| SIBA | C14H21N5O3S | 35899-54-8 | Details |
| SSTC3 | C23H17F3N4O3S2 | 1242422-09-8 | Details |
| ST3932 | C12H16N8O | 1246018-21-2 | Details |
| Src Inhibitor 3 | C34H32ClFN8O4 | 2380027-49-4 | Details |
| Sotalol-d6 hydrochloride；Sotalol D6 hydrochloride | C12H21ClN2O3S | 1246820-85-8 | Details |
| SP4206 | C30H37Cl2N7O6 | 515846-21-6 | Details |
| SM-276001 | C16H21N7O | 473930-22-2 | Details |
| Sofosbuvir impurity A | C22H29FN3O9P | 1496552-16-9 | Details |
| SIRT-IN-1 | C19H27N5O2S | 1431411-60-7 | Details |
| SKF89976A hydrochloride | C22H26ClNO2 | 85375-15-1 | Details |
| Product Total： Product Page： | ||||
| 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 | ||||